Inventor profile of:

Daniel E. Levy

City:

San Mateo, California

Country:

United States

Published Applications:

24

Last publication date:

2026-05-28

Top Assignees for applications by Daniel E. Levy

The entities that hold a legal rights for patent applications filed by inventor Levy Daniel E.:

Recent patent applications by Levy Daniel E.

Daniel E. Levy from San Mateo, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-28
US20260146048A1
Chemistry; metallurgy

NOVEL BISINDOLYLMALEIMIDE KINASE INHIBITORS

#2 | 2026-02-12
US20260042778A1
Chemistry; metallurgy

Polymorphs of N-Desmethyl Ruboxistaurin and Salts Thereof

#3 | 2025-07-17
US20250230164A1
Chemistry; metallurgy

POLYMORPHS OF SEPIAPTERIN AND SALTS THEREOF

#4 | 2025-07-17
US20250228821A1
Human necessities

N-DESMETHYL RUBOXISTAURIN AS A KINASE INHIBITOR

#5 | 2025-06-26
US20250206774A1
Chemistry; metallurgy

C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS

#6 | 2025-06-19
US20250195526A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING SEPIAPTERIN AND USES THEREOF

#7 | 2024-12-12
US20240409576A1
Chemistry; metallurgy

-ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions-

#8 | 2024-03-28
US20240100054A1
Human necessities

Pharmaceutical compositions comprising sepiapterin and uses thereof

#9 | 2024-02-08
US20240043426A1
Chemistry; metallurgy

Polymorphs of sepiapterin and salts thereof

#10 | 2022-03-17
US20220081443A1
Chemistry; metallurgy

POLYMORPHIC FORM OF SEPIAPTERIN

#11 | 2021-12-09
US20210379021A1
Human necessities

METHOD FOR PREPARING AND DELIVERING BISANTRENE FORMULATIONS

#12 | 2021-09-30
US20210300930A1
Chemistry; metallurgy

Polymorphs of sepiapterin and salts thereof

#13 | 2021-09-02
US20210269443A1
Chemistry; metallurgy

PHARMACEUTICALLY ACCEPTABLE SALTS OF SEPIAPTERIN

#14 | 2020-06-25
US20200199038A1
Chemistry; metallurgy

DICARBOXYLIC FATTY ACID DIMERS, AND DERIVATIVES THEREOF, AS STANDARDS FOR QUANTIFYING LEVELS IN BIOSPECIMENS

#15 | 2020-02-27
US20200061070A1
Human necessities

Pharmaceutical compositions comprising sepiapterin and uses thereof

#16 | 2020-01-09
US20200010469A1
Chemistry; metallurgy

Polymorphic form of sepiapterin

#17 | 2019-10-10
US20190308975A1
Chemistry; metallurgy

Polymorphs of sepiapterin and salts thereof

#18 | 2017-12-21
US20170362235A1
Chemistry; metallurgy

Adenylyl cyclase inhibitors, pharmaceutical compositions and method of use thereof

#19 | 2016-06-16
US20160168190A1
Chemistry; metallurgy

C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS

#20 | 2016-04-21
US20160108081A1
Chemistry; metallurgy

SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF

#21 | 2016-01-28
US20160024078A1
Chemistry; metallurgy

CaMKII inhibitors and uses thereof

#22 | 2015-06-25
US20150175650A1
Chemistry; metallurgy

SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF

#23 | 2011-11-17
US20110282093A1
Human necessities

HETEROBIFUNCTIONAL POLYETHYLENE GLYCOL REAGENTS

#24 | 2007-08-02
US20070179123A1
Human necessities

Methods and compositions for treating diseases associated with pathogenic proteins

InventorID:

1204268 ⎘